Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

NCT02580747 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Malignant Mesothelioma
Pancreatic Cancer
Ovarian Tumor
Triple Negative Breast Cancer
Endometrial Cancer
Other Mesothelin Positive Tumors

Interventions

BIOLOGICAL: anti-meso-CAR vector transduced T cells

Sponsor

Chinese PLA General Hospital